AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2015
Sep 3, 2015
29828_dirs_2015-09-03_05817955-2eff-40cb-b8ab-260d00d66519.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-09-01
Reporting Person: Alton Gregg H (EVP, Corp & Med Affairs)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-09-01 | Common Stock | M | 8625 | $24.295 | Acquired | 146047 | Direct |
| 2015-09-01 | Common Stock | M | 1375 | $23.755 | Acquired | 147422 | Direct |
| 2015-09-01 | Common Stock | S | 7905 | $102.3195 | Disposed | 139517 | Direct |
| 2015-09-01 | Common Stock | S | 3495 | $103.4922 | Disposed | 136022 | Direct |
| 2015-09-01 | Common Stock | S | 600 | $104.1118 | Disposed | 135422 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-09-01 | Non-Qualified Stock Option (right to buy) | $23.755 | M | 1375 | Disposed | 2020-01-28 | Common Stock (1375) | Direct |
| 2015-09-01 | Non-Qualified Stock Option (right to buy) | $24.295 | M | 8625 | Disposed | 2022-01-26 | Common Stock (8625) | Direct |
Footnotes
F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
F3: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F4: Sale prices reported for the transactions reported here range from $101.91 to $102.80. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F5: Sale prices reported for the transactions reported here range from $102.99 to $103.98. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F6: Sale prices reported for the transactions reported here range from $104.01 to $104.32. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.